Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

EMPAGLIFLOZIN vs EMSAM: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

EMPAGLIFLOZIN vs EMSAM: Safety Overview

Metric EMPAGLIFLOZIN EMSAM
Total FAERS Reports 37,059 113
Deaths Reported 1,624 0
Death Rate 4.4% N/A
Hospitalizations 12,216 1
Average Patient Age 64.3 yrs 55.2 yrs
% Female Patients 46.0% N/A
FDA Approval Date Aug 1, 2014 N/A
Manufacturer Cardinal Health 107, LLC N/A
Route ORAL N/A
Marketing Status Prescription N/A